Nasdaq

Roche awarded WHO prequalification for the cobas® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries

Every year, over 600,000 women worldwide are diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 ...
SheKnows

Hate Pelvic Exams? Now You Can Self-Collect Your Vaginal Samples for HPV Screening

Pelvic exams are no one’s idea of fun. No matter how many you’ve done, no matter how prepared you are, that moment when the ice cold speculum wrenches open your vagina never gets more comfortable. As ...
MedPage Today

FDA Approves New Self-Collection Option for HPV Testing

The FDA approved a new self-collection test to detect human papillomavirus (HPV) and identify women at risk for cervical cancer, maker Roche announced on Wednesday. "HPV self-collection offers an ...
Ibj.com

Roche Diagnostics hopes new self-collection HPV test will expand screening for cervical cancer risk

Roche Diagnostics is looking to a new screening tool to help women learn in a more private way if they are at increased risk for cervical cancer—a self-collection test to identify HPV. With the test, ...
Monthly Prescribing Reference

FDA Approves Roche’s Self-Collection Solution for HPV Screening

The HPV self-collection solution allows an individual to collect their own vaginal sample for HPV screening while at a health care facility. The Food and Drug Administration (FDA) has approved Roche’s ...
Nasdaq

Roche Granted WHO Prequalification For The Cobas HPV Test

(RTTNews) - Biopharmaceutical company Roche Holding AG (RHHBY), announced on Tuesday that its cobas HPV test for use on the cobas 6800/8800 Systems has been awarded the World Health Organization (WHO) ...
The American Journal of Managed Care

Roche Molecular Diagnostic's cobas HPV Test Approved by the FDA

A test that can detect the DNA of the human papilloma virus (HPV), to confirm the need for cervical cancer screening in women 25 years and older, has gained the FDA’s support as a primary screening ...
KOMU

FDA approves self-collection HPV tests as an alternative to Pap smears

How does the test work, and who is eligible?Kay said self-collection tests work by inserting a long cotton swab into the vagina and swirling it for 20 to 30 seconds or using a special collection ...
The Indianapolis Star

Dread HPV testing? Self-collection Roche test approved by the FDA is available now

Pap tests and HPV testing are a vital part of women's health care, but many people dread the invasive examination every three years. For some women, particularly sexual violence survivors, getting ...
PopSugar

You May Be Able to Screen Yourself For Cervical Cancer Soon — Here's What to Know

I'll be the first to admit, getting a Pap smear is one of my least favorite doctor's appointments to schedule. While a crucial aspect of testing for HPV and cervical cancer, the procedure can be very ...
DrBicuspid

FDA approves 1st HPV test for primary cervical cancer screening

The U.S. Food and Drug Administration (FDA) has approved a human papillomavirus (HPV) DNA test for women 25 and older that can be used to determine whether these women should have additional ...